Gabelli Healthcare&wellness (GRX) Technical Analysis
$9.64▲0.21%
Market is closed - opens 7 PM, 07 Jul 2025
Insights
- Gabelli Healthcare&wellness is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Gabelli Healthcare&wellness stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Gabelli Healthcare&wellness stock is Range bound.
- Based on analysis of the Pivot Points, the current market trend for Gabelli Healthcare&wellness stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 56.21 | Neutral |
Stochastic | 81.4, 61.16 | Neutral |
Ultimate Oscillator | 48.51 | Neutral |
Stochastic Relative Strength Index | 81.49, 65.06 | Neutral |
Moving Average Convergence Divergence | -0.01, -0.03 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.45 | Sell |
20 | 9.5 | Sell |
50 | 9.53 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.49 | Buy |
20 | 9.49 | Sell |
50 | 9.55 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.45 | Neutral |
20 | 9.49 | Neutral |
50 | 9.51 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.51 | Buy |
20 | 9.47 | Buy |
50 | 9.41 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.55 | Buy |
20 | 9.49 | Buy |
50 | 9.45 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 9.94 |
Resistance L2 | 9.79 |
Resistance L1 | 9.68 |
Pivot Point | 9.53 |
Support L1 | 9.42 |
Support L2 | 9.27 |
Support L3 | 9.16 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.